pharma · Acute Myeloid Leukemias · Breast Cancer
Syndax Pharmaceuticals
Syndax Pharmaceuticals clinical programs — 16 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 730 3rd Ave, Floor 9, New York, NY 10017, US
- Employees
- 325
- Programs
- 47
- Drugs
- 29
- Patents
- 6
Syndax Pharmaceuticals projects
16 ClinicalTrials.gov programs sponsored by Syndax Pharmaceuticals.
Syndax Pharmaceuticals has 16 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Axatilimab
Syndax Pharmaceuticals
Solid Tumor
1 trial -
Entinostat
Syndax Pharmaceuticals
Drug Interaction
1 trial -
Entinostat
Syndax Pharmaceuticals
Fallopian Tube Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Neoplasms
2 trials -
Entinostat
Syndax Pharmaceuticals
Pancreas Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Renal Impairment
1 trial -
Entinostat
Syndax Pharmaceuticals
Volunteers
2 trials -
Revumenib
Syndax Pharmaceuticals
Acute Leukemia
1 trial -
Revumenib
Syndax Pharmaceuticals
Blinatumomab
1 trial -
Revumenib
Syndax Pharmaceuticals
Refractory Acute Myeloid Leukemia
1 trial -
Revumenib
Syndax Pharmaceuticals
Relapsed/Refractory Leukemias
1 trial -
SNDX-275
Syndax Pharmaceuticals
Breast Cancer
1 trial -
SNDX-5613
Syndax Pharmaceuticals
Acute Myeloid Leukemias
1 trial -
SNDX-5613-0708
Syndax Pharmaceuticals
Acute Myeloid Leukemias
1 trial -
entinostat
Syndax Pharmaceuticals
Lung Cancer
1 trial
Frequently asked questions
How many clinical projects does Syndax Pharmaceuticals have?
16 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.